JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells

BACKGROUND: Although gefitinib brings about tremendous advances in the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, most of patients become incurable due to drug resistance. JuBei oral liquid (JB) has been widely used to treat pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Zhenzhen, Chen, Qiufang, Zheng, Xiulan, Wang, Kai, Duan, Yalei, Xiao, Kang, Jia, Zhirong, Ding, Xuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423349/
https://www.ncbi.nlm.nih.gov/pubmed/32821122
http://dx.doi.org/10.2147/OTT.S254464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423349/
https://www.ncbi.nlm.nih.gov/pubmed/32821122
http://dx.doi.org/10.2147/OTT.S254464

Ejemplares similares